Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance

By Zhao Xinmin  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 733-743

Springer Publishing Company

Access to resources Recommend Favorite

Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study

By Ripamonti Carla  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1177-1184

Springer Publishing Company

Access to resources Recommend Favorite

Zoledronic acid in lung cancer with bone metastases: a review

By Isla Dolores   Afonso Ruth   Bosch-Barrera Joaquim   Martínez Natividad  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 4, 2013-04 ,pp. : 421-426

Informa Healthcare

Access to resources Recommend Favorite

Pain Control with Zoledronic Acid in Patients with Breast Cancer and Metastatic Bone Disease

By Cinzia Nigro   Michela Donadio   Mara Ardine   Alessandra Beano   Marinella Mistrangelo   Zaira Coccorullo   Oscar Bertetto  

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 257-263

Adis International

Access to resources Recommend Favorite

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases

By                

Experimental and Therapeutic Medicine, Vol. 8, Iss. 2, 2014-01 ,pp. : 539-544

Spandidos Publications

Access to resources Recommend Favorite